Sandoz 9M net sales rise 5% at constant currency

Sandoz narrowed 2026 net-sales growth guidance to 5—6% at CC and raised core-EBITDA margin guidance to 23.0—23.5%. Q3 net sales were $2.9B, up 5% at CC; biosimilars $1.0B, up 17% at CC.Material DetailsContext by AI AnalystThis is a mid-cycle adjustment: sales narrowed but margins raised on stronger…